Breast Cancer Weight Loss Trial
Welcome to the Breast Cancer Weight Loss (BWEL) Study web site!
The BWEL study is looking at whether losing weight, by eating less and exercising more, changes the risk of cancer recurrence in women who have been diagnosed with early breast cancer. The study is enrolling more than 3000 women with breast cancer in the United States and Canada.
The results of this study will help us understand if losing weight after breast cancer diagnosis is important to decrease the risk of breast cancer recurrence.
If you are participating in the BWEL study as a participant or a coach, Log In here:
The BWEL study is sponsored by the National Cancer Institute and the Alliance for Clinical Trials in Oncology.
For more information please see:
Clinicaltrials.gov1-800-422-6237